News tagged with novartis
Scientists identify new class of antimalarial compounds
An international team led by scientists from the Genomics Institute of the Novartis Research Foundation (GNF) and The Scripps Research Institute has discovered a family of chemical compounds that could lead ...
Nov 17, 2011 |
3 / 5 (2) |
2
|
Chip-in-a-pill may be approved in 2012
(PhysOrg.com) -- Giant Swiss pharmaceutical company Novartis AG, based in Basel, is developing a pill containing an embedded microchip, which it hopes to submit for regulatory approval in Europe within 18 ...
Medicine & Health / Medications
Nov 10, 2010 |
4.9 / 5 (18) |
10
|
Novel epigenetic patterns involved in cell fate regulation
(PhysOrg.com) -- Scientists from the Friedrich Miescher Institute for Biomedical Research (FMI) publish exciting new results on the regulation of cell fate in the scientific journal Nature. They identified ...
Dec 15, 2011 |
5 / 5 (1) |
0
|
FDA approves new swine flu vaccine
(AP) -- The Food and Drug Administration approved the new swine flu vaccine Tuesday, a long-anticipated step as the government works to get vaccinations under way next month. Health and Human Services Secretary ...
Medicine & Health / Medications
Sep 15, 2009 |
not rated yet |
0
Is a repeat flu shot needed? This fall, maybe not
(AP) -- Vaccine makers said this month they plan to make a record amount of flu vaccine for this fall and winter - enough for more than half the population. It's just not clear all those people will need ...
Medicine & Health / Diseases, Conditions, Syndromes
May 27, 2011 |
not rated yet |
0
Extending the shelf life of antibody drugs
A new computer model developed at MIT can help solve a problem that has plagued drug companies trying to develop promising new treatments made of antibodies: Such drugs have a relatively short shelf life because they tend ...
Medicine & Health / Medical research
Jun 29, 2009 |
2 / 5 (1) |
1
UNICEF discloses vaccine prices for 1st time
UNICEF is for the first time publicizing what drugmakers charge it for vaccines, as the world's biggest buyer of lifesaving immunizations aims to spark price competition in the face of rising costs.
Medicine & Health / Medications
May 29, 2011 |
5 / 5 (3) |
1
Imaging against multiple sclerosis: Iodinated radiotracer candidate for PET and SPECT imaging
(PhysOrg.com) -- A first-line treatment for relapsing forms of multiple sclerosis (MS) was approved in September 2010 by the US Food and Drug Administration: FTY720 (fingolimod, Gilenya), which acts as a sphingosine ...
Feb 04, 2011 |
5 / 5 (3) |
0
New insights for a therapeutic approach in glioblastoma
(PhysOrg.com) -- Scientists from the Friedrich Miescher Institute for Biomedical Research have identified a new and important molecular player in glioblastoma. The amount of the MNK1 kinase is not only dramatically ...
Mar 18, 2011 |
not rated yet |
0
FDA approves Novartis brain tumour drug
Swiss pharmaceutical company Novartis said Saturday that the US drug Food and Drug Administration had approved a drug for treating certain benign brain tumours which previously required surgery.
Medicine & Health / Medications
Oct 30, 2010 |
not rated yet |
0
Continuous drug manufacturing offers speed, lower costs
Traditional drug manufacturing is a time-consuming process. Active pharmaceutical ingredients are synthesized in a chemical manufacturing plant and then shipped to another site, where they are converted into ...
Mar 12, 2012 |
5 / 5 (4) |
0
Switzerland restricts use of GlaxoSmithKline swine flu vaccine
Switzerland on Friday restricted the use of British drugs group GlaxoSmithKline's swine flu vaccine Pandemrix, excluding pregnant women, minors and people over the age of 60.
Medicine & Health / Medications
Oct 30, 2009 |
2.5 / 5 (2) |
0
Novartis says swine flu vaccine boosts profit
Swiss pharmaceutical group Novartis posted on Tuesday an 8.0-percent jump in core annual net profit for 2009, saying that business had been boosted by sales of swine flu vaccine.
Jan 26, 2010 |
5 / 5 (1) |
0
Novartis denies problems with swine flu vaccine
Swiss pharmaceutical group Novartis on Monday denied that it faced hurdles in gaining regulatory approval in Switzerland for one of its swine flu vaccines because of possible bacterial contamination.
Medicine & Health / Medications
Oct 26, 2009 |
not rated yet |
0
World-first swine-flu vaccine trial reveals one dose provides 'strong immune response'
Results from the first swine-flu vaccine trials taking place in Leicester reveal a strong immune response after just one dose.
Medicine & Health / Medications
Sep 03, 2009 |
not rated yet |
0
Novartis
Novartis International AG is a multinational pharmaceutical company based in Basel, Switzerland, ranking number one in revenues, which accounted over $53 billion in 2008, and number three in sales, which accounted 36.172 billon in 2008 . Novartis is one of the largest healthcare companies in the world and a leading giant among pharmaceutical companies. Novartis manufactures drugs such as clozapine (Clozaril), diclofenac (Voltaren), carbamazepine (Tegretol), valsartan (Diovan), imatinib mesylate (Gleevec / Glivec), cyclosporin A (Neoral / Sandimmun), letrozole (Femara), methylphenidate (Ritalin), terbinafine (Lamisil), and others. Novartis owns Sandoz, a large manufacturer of generic drugs. The company formerly owned the Gerber Products Company, a major infant and baby products producer, but sold it to Nestlé on 1 September 2007.
Novartis is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA).
For more information about Novartis, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
